Emergent received $75 million contract option from BARDA to procure doses of CYFENDUS (Anthrax Vaccine)
On Nov. 28, 2023, Emergent BioSolutions announced that the Biomedical Advanced Research and Development Authority (BARDA) within the…
-
-
Novavax’s updated protein-based COVID-19 vaccine now option for all 194 WHO member states
On Nov. 28, 2023, Novavax announced that Nuvaxovid XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) had been granted Emergency Use Listing…
-
Japan’s MHLW approved CSL and Arcturus’s self-amplifying mRNA vaccine approved for COVID in adults
On Nov. 28, 2023, CSL and Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor and Welfare (MHLW)…
-
U.S. Centers for Disease Control and Prevention Tuberculosis Trials Consortium launched new TB clinical trial
On Nov. 27, 2023, the CDCﾒs Tuberculosis Trials Consortium (TBTC) announced that it had launched an international clinical…
-
FDA approved first therapy for rare type of non-cancerous tumorsﾠ
On Nov. 27, 2023, the U.S. Food and Drug Administration approved SpringWorks’ Ogsiveo (nirogacestat) tablets for adult patients…
-
University of Wisconsin-Madison reported spike in premature births caused by COVID, halted by vaccines
On Nov. 27, 2023, University of Wisconsin-Madison researchers released a study that showed COVID-19 caused an alarming surge…
-
EC approved KAFTRIOﾮ in combination with Ivacaftor for treatment of children with Cystic Fibrosis ages 2 through 5
On Nov. 23, 2023, Vertex announced that the European Medicines Agency (EMA) had validated a Type II variation…
-
Upsurge of respiratory illnesses reported among children in Northern China
On Nov. 23, 2023, the World Health Organization (WHO) announced that it was monitoring data from Chinese surveillance…
-
Biotechnology | Clinical Research | COVID-19 | FDA | Infectious Disease | Medicine | NIH | Therapeutics | Vaccine
FDA issued final guidance on developing drugs for COVID-19 treatment and preventionﾠ
On Nov. 22, 2023, the U.S. Food and Drug Administration (FDA) issued the final guidance COVID-19: Developing Drugs…
-
WHO upgraded BA.2.86 to COVID-19 variant of interest
On Nov. 21, 2023, the World Health Organization (WHO) reported that the BA.2.86 variant had been reported in…
-
USDA introduced multi-year plan to strengthen U.S. Genebank management of plant germplasm
On Nov. 17, 2023, the U.S. Department of Agriculture’s (USDA) announced the National Strategic Germplasm and Cultivar Collection…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
Highly pathogenic Avian influenza spread in Oregon
On Nov. 17, 2023, the Oregon Department of Agriculture has new confirmed cases of avian influenza, and the…
-
Biology | Cardiology | FDA | Medical Device
Masimo W1 Medical Watch received FDA 510(k) clearance for over-the-counter and prescription Use
On Nov. 17, 2023, Masimo announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter…
-
CDC and FDA expedited availability of additional doses of new RSV immunization for infants
On Nov. 16, 2023, the CDC announced the release of more than 77,000 additional doses of Beyfortusﾙ (nirsevimab-alip…
-
CDC | Life Science History | Measles | WHO
Global measles threat continued to grow as another year passed with millions of children unvaccinated
On Nov. 16. 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that Following years of…
-
Vertex and CRISPR Therapeutics announced authorization of first CRISPR/Cas9 gene-edited therapy by UK MHRA for treatment of Sickle Cell Disease
On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…
-
FDA granted Marketing Authorization of first test for chlamydia and gonorrhea with at-home sample collection
On Nov. 15, 2023, the U.S. Food and Drug Administration granted marketing authorization to LetsGetChecked for the Simple…
-
CPRIT invested $63 million to bring innovative researchers and companies to Texas
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
-
Mule deer tested positive for chronic wasting disease in Yellowstone National Park
On Nov. 14, 2023, Yellowstone National Park and the Wyoming Game and Fish Department (WGFD) officials confirmed the…
-
WHO reported Marburg virus disease outbreak in Equatorial Guinea
On Nov. 13, 2023, the World Health Organization (WHO announced that the Ministry of Health and Social Welfare…
-
JAMA reported widening gender gap in life expectancy in the U.S. due to COVID-19
On Nov. 13, 2023, the Journal JAMA reported evidence that showed COVID-19 had widened the gendered life expectancy…
-
USDA researchers confirmed six unique strains of African Swine fever virus
On Nov. 13, 2023, the U.S. Department of Department of Agriculture (USDA) announced that researchers have reclassified the…
-
The White House lanuched Initiative on Women’s Health Research
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenﾒs Health Research, an effort led…
-
Surgeons in New York announced world’s first eye transplant
On Nov. 10, 2023, surgeons in New York announced they had performed the first-ever whole-eye transplant in a…
-
CDC published first preliminary in-season flu burden estimates
On Nov. 10, 2023, the Centers for Disease Control and Prevention (CDC) estimated that from October 1, 2023,…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH
FDA cleared first COVID-19 home antigen test
On Nov. 9, 2023, the U.S. Food and Drug Administration (FDA) cleared for marketing the first over-the-counter (OTC)…
-
FDA approved first treatment for patients with rare inherited blood clotting disorder
On Nov. 9, 2023, the U.S. Food and Drug Administration approved ‘ Takeda PharmaceuticalsVAdzynma, the first recombinant (genetically…
-
FDA approved first vaccine to prevent disease caused by chikungunya virus
On Nov. 9, 2023, the U.S. Food and Drug Administration (FDA) approved Valneva’s Ixchiq, the first chikungunya vaccine….
-
Monica Bertagnolli, M.D. took the helm at National Institutes of Health
On Nov. 9, 2023, the National Institute of health (NIH) announced that Monica M. Bertagnolli, M.D., had begun…
-
FDA approved new medication for chronic weight management
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
